TP53 deletions were more frequent than mutations and were detected in 19/65 cases (29.2%) and 6/48 cases (12.5%), respectively, confirming the data of previous publications demonstrating higher incidence of TP53 deletion than gene mutation in cancer [23,24,25]. The gene discussed is TP53; the disease is cancer.